Momelotinib 150mg tablets
- SNOMED code
42655911000001109- Active compound
- Momelotinib
- Preferred name basis
- rINN - Recommended International Non-proprietary
- Prescribable
- ✅ Yes
- Dose form
- Discrete
- Dose size and units
- 1 tablet, tablet
- Ingredients
- Momelotinib dihydrochloride monohydrate, ID: 1366447007
— 150 mg
based on base substance
- Form & Route
- tablet.oral
Oral tablet, Oral - Controlled drug
- No Controlled Drug Status
Products
Omjjara 150mg tablets (GlaxoSmithKline UK Ltd)
Omjjara 150mg tablets
- SNOMED code
42644111000001109- Supplier
- GlaxoSmithKline UK Ltd
- Licensed as
- Medicines - MHRA/EMA
- EMA (European Medicines Agency) Monitoring
- ▼ Yes, black triangle marked
- Availability restrictions
- None
- Licensed route
- Oral
| Pack name & code | Status | GTIN, EAN barcodes | Price | Prescribing | Reimbursement | Pack |
|---|---|---|---|---|---|---|
Omjjara 150mg tablets (GlaxoSmithKline UK Ltd) 30 tablet42644211000001103 ref. pack | 💯 Available Legal category: POM | 505429000662905054290006599End: 5054290006599End: 050542900066295054290010619 | NHS Indicative Price £5,650 | • Hospital |
| — |
Reference packs
Momelotinib 150mg tablets 30 tablet
- SNOMED code
42644011000001108- Quantity and unit
- 30 tablet
- Packs